Silence Therapeutics PLC - ADR (SLN) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,07%	1 101,37	−0,81	−0,07%	—	1 102,18	1 096,24	1 103,05	1 090,35	—	—
SIXC Communications SIXC Communications	SIXC −0,47%	613,35	−2,89	−0,47%	—	616,24	616,24	617,68	609,10	—	—
SIXE Energy SIXE Energy	SIXE +0,77%	1 198,83	+9,11	+0,77%	—	1 189,72	1 194,74	1 202,79	1 188,58	—	—
SIXI Industrials SIXI Industrials	SIXI +1,75%	1 755,95	+30,26	+1,75%	—	1 725,69	1 730,02	1 762,99	1 730,02	—	—
SIXM Financials SIXM Financials	SIXM −0,79%	638,51	−5,11	−0,79%	—	643,62	643,13	643,17	632,59	—	—
SIXR Staples SIXR Staples	SIXR +1,65%	843,52	+13,73	+1,65%	—	829,79	832,32	845,25	832,32	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +1,19%	215,95	+2,55	+1,19%	—	213,40	213,40	216,07	213,40	—	—
SIXT Technology SIXT Technology	SIXT −1,48%	3 138,91	−47,01	−1,48%	—	3 185,92	3 160,89	3 178,72	3 102,60	—	—
SIXU Utilities SIXU Utilities	SIXU +2,80%	934,37	+25,43	+2,80%	—	908,94	912,57	934,91	912,57	—	—
SIXV Health care SIXV Health care	SIXV −0,10%	1 477,43	−1,53	−0,10%	—	1 478,96	1 478,17	1 482,91	1 466,65	—	—
SIXY Discretionary SIXY Discretionary	SIXY −1,05%	2 380,19	−25,17	−1,05%	—	2 405,36	2 390,34	2 402,53	2 359,18	—	—

SLN:NASDAQ

Silence Therapeutics PLC - ADR

7,84 USD

−1,63%

(−0,13) 1 D

7,69 USD

−1,91% (−0,15)

Etter stengetid

Stengt: 23. apr., 16:00:00 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for SLN …

Åpne

7,90 USD

Høy

8,40 USD

Lav

7,78 USD

Markedsverdi

370,31 mill.

Snittvolum

400,45k

Volum

0,00

52 u høy

8,40 USD

52 u lav

3,08 USD

EPS

−1,88 USD

Beta

1,34

Utestående aksjer

47,23 mill.

Antall ansatte

Relaterte aksjer

Biomarin Pharmaceutical Inc

Nyhetssaker

Fra kilder på nettet

TechStock²

for 14 minutter siden

US Stock Market Today: Nasdaq Futures Ride Intel Rally as Oil Shock Keeps Dow Under Pressure

Yahoo Finance

for 22 minutter siden

Markets Drift as Oil Stays Elevated and Intel Jumps: Dow Jones, S&P, Nasdaq, Wall Street Futures

MarketBeat

for 34 minutter siden

Microchip Technology (NASDAQ:MCHP) Hits New 52-Week High - Time to Buy?

StockStory

for 36 minutter siden

NDAQ Q1 Deep Dive: AI and Cloud Growth Drive Strong Start for Nasdaq

Profil

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia

Om Silence Therapeutics PLC - ADR

Administrerende direktørCraig A Tooman

Ansatte88

Grunnlagt1994

Hovedkontor-

Sektor-

Nettstedsilence-therapeutics.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	142,00k	224,00k	159,00k	34,00k
Varekostnad	54,00k	85,00k	64,00k	12,00k
Direkte driftskostnader	54,00k	85,00k	64,00k	12,00k
Utgifter til forskning og utvikling	18,13 mill.	15,28 mill.	17,96 mill.	8,92 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	7,68 mill.	5,13 mill.	5,80 mill.	3,73 mill.
Driftskostnader	25,82 mill.	20,41 mill.	23,76 mill.	12,65 mill.
Totale driftskostnader	25,87 mill.	20,49 mill.	23,82 mill.	12,66 mill.
Driftsinntekter	−25,73 mill.	−20,27 mill.	−23,66 mill.	−12,63 mill.
Andre ikke-operasjonelle inntekter	969,00k	861,00k	770,00k	865,00k
EBT inkludert uvanlige elementer	−28,53 mill.	−27,34 mill.	−20,96 mill.	−11,77 mill.
EBT uten uvanlige elementer	−28,53 mill.	−26,02 mill.	−20,96 mill.	−11,77 mill.
Kostnad for inntektsskatt	-	10,00k	1,00k	-
Faktisk avgiftssats	-	−0,04 %	-	-
Andre driftskostnader	-	-	-	-
Nettoinntekt	−28,53 mill.	−27,35 mill.	−20,96 mill.	−11,77 mill.
Netto fortjenestemargin	−20 091,55 %	−12 211,61 %	−13 181,13 %	−34 617,65 %
Resultat per aksje	−0,60	−0,55	−0,15	−0,27
Rente- og investeringsinntekter	-	-	-	15,00k
Rentekostnader	-	-	-	-
Netto rentekostnader	-	-	-	15,00k
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	−25,59 mill.	−20,12 mill.	−23,50 mill.	−12,52 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning